Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

Cross-reactivity

Cross-reactivity

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

[Effect of Application Device Design on Scalp Delivery of Topical Minoxidil Formulations].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same journal

[Survey of Pharmaceutical Interventions in Outpatient Cancer Chemotherapy].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same journal

Effects of Fluctuating Triglyceride Levels on Initial and Steady-state Serum Amiodarone Concentrations in Japanese Patients: A Retrospective Study.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same journal

[Dynamic Oligomerization Processes and Functional Characterization of Bacterial ClpP Protease].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same journal

[Structural Analysis Using Cryo-electron Microscopy for Protein-based Drug Design].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Same journal

[Expansion of Targeted Protein Degradation for Targeting Aggregate-prone Proteins and Mitochondrial Proteins].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026

Search research articles

Related Experiment Video

Updated: May 27, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

[Vaccine does make sense, until used].

Toshi-Hiko Kobayashi¹

¹Alumni Association, Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. toshi.yakuyu@mol.f.u-tokyo.ac..jp

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan

|December 2, 2011

Summary

Major pharmaceutical companies are increasing investment in the vaccine market due to its growth potential and intellectual property advantages. Recent influenza scares have spurred industry and government collaboration, boosting vaccine development and market expansion.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Related Experiment Videos

Last Updated: May 27, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Area of Science:

Pharmaceuticals
Immunology
Biotechnology

Context:

Historically, drug companies prioritized small molecule drugs for chronic diseases.
The vaccine market was perceived as slow-growing, low-priced, and undifferentiated.
Recent influenza scares have significantly shifted this perception, highlighting vaccine market potential.

Purpose:

To analyze the reasons behind major pharmaceutical companies' increased investment in the vaccine business.
To explore the evolving landscape of the vaccine market and its strategic importance.

Summary:

The vaccine market is experiencing accelerated growth, projected at nearly 10% annually, driven by factors like influenza scares.
Pharmaceutical giants like GSK, Pfizer, Johnson & Johnson, Merck, Novartis, and Sanofi-Aventis are actively acquiring vaccine manufacturers and expanding their portfolios.
Vaccine development offers advantages over small molecules, including reduced intellectual property risks and high barriers to biosimilar competition due to complex manufacturing.

Impact:

This strategic shift indicates a significant transformation in the pharmaceutical industry's focus towards biologics and vaccines.
Increased investment and collaboration are expected to accelerate vaccine innovation and market accessibility.
The trend suggests a growing recognition of vaccines as a lucrative and strategically vital segment within the pharmaceutical sector.